The existing peptide cGMP facility (60,000 sq ft) has been already inspected by US-FDA multiple times and is ISO 9001/ISO 13485 certified to fully comply with cGMP guidelines for peptide drug manufacturing. Multiple numbers of isolated peptide synthesis and purification suites in the new facility enable several commercial projects at the same time. High end equipments such as large scale solid phase and liquid phase reactors, HPLC columns and tray lyophilizers will allow CPC to manufacture hundreds of Kilograms of different peptides with improved delivery options and reduced costs.
"With the completion and commissioning of our new cGMP facility, we are poised to be the largest peptide manufacturer in the industry" says Dr. Shawn Lee, Chairman and CEO of CPC group. "Along with the existing GMP facility the combined capability will be critical in offering our valued customers with flexibility, sustainability and increasing demands for scale up and commercial scale manufacturing".
About CPC Scientific
CPC scientific is a trusted provider of high quality peptide based products to pharmaceutical and biotechnology companies and academic researchers. CPC offers catalog peptides, custom peptide synthesis, peptide arrays and libraries, cGMP manufacturing of peptide APIs and Generics and is a world leader in complex peptide modification services. CPC provides FFS and FTE services as well as process development and validation, stability studies, regulatory support and documentation. Its R&D center and Headquarters is located in Sunnyvale, California. For more information please visit us at www.cpcscientific.com
Media Contact
Dr. Jyothi Thundimadathil
Director
CPC Scientific Inc
E-mail: Jyothi@cpcscientific.com
Web: www.cpcscientific.com